Alternatives to Eos SENOLYTIX, .
Eos SENOLYTIX, . is a Biotech tool: develops senolytic drugs to clear senescent cells and promote cellular rejuvenation. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotech companies to Eos SENOLYTIX, .
- Website JUJuvenescence Ltd.47BiotechGeorge Town, Cayman Islands$150.0M
Biotech company focused on developing therapies to extend human healthspan and lifespan.
- Website
BioAge Labs53BiotechNew Haven, United StatesBioAge Labs is a biotechnology company focused on developing therapies to extend human healthspan and lifespan.
- Website
Aerska54BiotechDublin, Ireland$32.0MIrish BioTech startup Aerska raises €32 million to enable loved ones to live longer.
- Website JUJuvenescence Uk Ltd47BiotechLondon, United Kingdom$150.0M
Biotechnology company focused on developing therapies to extend human healthspan and reverse aging.
- Website LILife Biosciences49BiotechnologyBoston, USA$100.0M
Developing epigenetic reprogramming drugs for age restoration.
- Website
Adaptive Biotechnologies69BiotechSeattle, United States$300.0MLeveraging the adaptive immune system to diagnose and treat disease.
- Website
Lifespan45LongevityNew York, United States$1.0MBiotech company
- Website
BeiGene64BiotechCambridge, United States$358.0MA global oncology company developing and commercializing innovative cancer treatments.
- Website
HealthSpan Labs48BiotechSan Diego, United StatesBiotechnology company developing novel therapeutics to promote healthy longevity by understanding aging pathways.
- Website
Synthace62BiotechLondon, United Kingdom$60.6MSynthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.
- Website
Cue Biopharma, .62BiotechBoston, United States$10.0MDeveloping engineered biologics to harness the immune system for disease treatment.
- Website LELexeo Therapeutics61BiotechNew York City, United States$495.0M
Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
- Website
ImCheck Therapeutics60BiotechMarseille, France$164.0MImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.
- Website
Caris Life Sciences59BiotechIrving, United States$700.0MCaris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
- Website
Amicus Therapeutics57BiotechPhiladelphia, United States$200.0MBiotechnology company focused on developing treatments for rare metabolic diseases.
- Website
Harmony Biosciences Holdings57BiotechPlymouth Meeting, United States$400.5MBiopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.
- Website
Anamnesis Bio42Biotechתל אביב - יפו, IsraelDeveloping novel therapeutics for neurodegenerative diseases using advanced biological insights.
- Website
Guardant Health57BiotechRedwood City, United States$900.0MGuardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.
- Website
Sylentis55BiotechMadrid, Spain$135.0MOphthalmic pharmaceutical company developing novel treatments for ocular diseases.
- Website
Alector55BiotechSouth San Francisco, United States$162.5MBiotechnology company developing immuno-neurology therapies for neurodegenerative diseases.
Showing the 20 closest matches. See the rest on the Eos SENOLYTIX, . profile.
Compare Eos SENOLYTIX, . head to head
Side by side on what each one does, what it costs, and what real users report.